Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

US: Trump Reschedules Cannabis to Schedule III: What It Means

Matthew Ma

Lifehack

Saturday 20 Dec 2025

Trump's executive order moves cannabis to Schedule III, easing tax burdens and opening research, but questions remain about FDA regulation and Big Pharma.

Despite the jubilation, experts urge cautious optimism. Rescheduling is not full legalization or decriminalization. It does not automatically make products safer or more affordable for consumers, nor does it protect patients from housing or employment discrimination based on cannabis use.

Furthermore, the entry of federal agencies like the FDA into the regulatory picture creates a new "wild card." Jeffrey Miller, CEO of HoneyProjects, warns that while the demise of 280E is a victory, reclassification could become a tool for "Big Pharma or federal regulators to preempt state-legal systems." There is a palpable fear among some entrepreneurs that strict FDA regulations could favor large pharmaceutical companies over existing state-legal operators, potentially altering the landscape of the $38 billion sector.

Ultimately, while Trump's executive order is a monumental step towards aligning federal policy with political and scientific realities, it leaves many questions unanswered. Whether this reform will primarily benefit patients and small businesses or pave the way for corporate consolidation remains to be seen. For now, however, the cannabis industry is breathing a collective sigh of relief as it steps out of the shadow of Schedule I.

https://vocal.media/lifehack/trump-reschedules-cannabis-to-schedule-iii-what-it-means

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!